If you have a condition such as chronic obstructive respiratory disease or pulmonary fibrosis, it is possible that you will eventually require supplemental oxygen therapy as a main treatment method if you do not already.

With around 65 million patients worldwide, chronic obstructive pulmonary disease (COPD) is anything but uncommon. In fact, it’s one of the most prevalent lung conditions in the world behind asthma. However, despite these statistics, COPD is labeled an “invisible illness.” Many people suffer with this condition in silence, and society as a whole tends to stigmatize it by misunderstanding what its causes are and what life is like with this condition.

Chronic obstructive pulmonary disease (COPD) is one of the diseases with the greatest financial burdens worldwide and within the United States. Studies have shown that the average annual COPD-related expenditure is around $4,147. And while 51% of these costs are covered by Medicare according to the Centers for Disease Control and Prevention (CDC), that still leaves roughly $2,000 a year that COPD patients need to spend out-of-pocket. Combine this with the cost of aging and limited retirement funds and it’s not hard to see why COPD is such a major financial burden for so many people.

Nowadays, life is all about choices. We get to choose where we shop, eat, work, and much more. For the most part, this is a positive thing because it allows us the freedom to create a life that’s suited to our wants and needs. Oxygen patients, for example, can benefit from many decades of improvement in oxygen device technology and they have a wider array of options available to them than ever before including oxygen tanks, liquid oxygen tanks, stationary oxygen concentrators, and portable oxygen concentrators.

Supplemental oxygen therapy, or simply “oxygen therapy,” is the use of medical-grade oxygen to treat a variety of conditions. In hospitals, short-term oxygen therapy is used to help patients recover from surgery or acute conditions, but oxygen can also be administered for long-term in-home use in people with chronic lung diseases like COPD and cystic fibrosis.